Video

The Emerging Role of Immunotherapy in Breast Cancer

"I think immunotherapy has certainly arrived for breast cancer," said Rita Nanda, MD.

Rita Nanda, MD: So the role of immunotherapy has really evolved this year, for both advanced-stage disease and hopefully for early-stage disease in the not-too-distant future. I think immunotherapy has certainly arrived for breast cancer. We saw our first approval advanced PDL-1+, triple-negative breast cancer earlier this year with the approval of atezolizumab and Nab-paclitaxel, based on the IMpassion130 trial. So there are a number of other trials going on that are helping us understand how better to sequence immunotherapy with chemotherapy; are there different chemotherapy backbones that might be as effective or more effective than nab-paclitaxel in any particular situation; as well as combination trials that are ongoing that hopefully will enhance and boost the number of patients who can benefit from immunotherapy in patients with advanced-stage disease.

Related Videos
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
Image Credit: © Krakenimages.com - stock.adobe.com
Image Credit: © Cavan - stock.adobe.com